UNLIMITED TURBO SHORT - JOHNSON & JOHNSON Share Price

Certificat

DE000PF539E6

Delayed Deutsche Boerse AG 10:35:22 11/06/2024 pm IST
3.62 EUR +2.55% Intraday chart for UNLIMITED TURBO SHORT - JOHNSON & JOHNSON
Current month-0.56%
1 month+4.44%
Date Price Change
11/24/11 3.62 +2.55%
10/24/10 3.53 +0.28%
07/24/07 3.52 -0.28%
06/24/06 3.53 -1.40%
05/24/05 3.58 +3.77%

Delayed Quote Deutsche Boerse AG

Last update June 11, 2024 at 10:35 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying JOHNSON & JOHNSON
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PF539E
ISINDE000PF539E6
Date issued 20/01/2021
Strike 184 $
Maturity Unlimited
Parity 10 : 1
Emission price 4.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.68
Lowest since issue 0.78
Spread 0.01
Spread %0.28%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
147.1 USD
Average target price
171.7 USD
Spread / Average Target
+16.71%
Consensus